Number of pages: 100 | Report Format: PDF | Published date: October 03, 2022
Historical Years – 2023 | Base Year – 2023 | Forecasted Years – 2023-2032
According to the deep-dive market assessment study by Growth Plus Reports, the global diabetic foot ulcer treatment market was valued at US$ 3.95 billion in 2023 and is expected to register a revenue CAGR of 5.7% to reach US$ 6.16 billion by 2032.
Diabetic Foot Ulcer Treatment Market Fundamentals
A diabetic foot ulcer is a common complication associated with diabetes mellitus, particularly in individuals with poorly controlled blood sugar levels. It is a chronic wound that develops on the feet, most commonly on the bottom surface or the sides. These ulcers result from various factors, including neuropathy (nerve damage), poor circulation, and infection susceptibility. The treatment of diabetic foot ulcers is a complex and multidisciplinary process involving various medical professionals. The primary goals are to promote wound healing, prevent infection, and reduce the risk of complications such as amputation.
Diabetic Foot Ulcer Treatment Market Dynamics
The increasing prevalence of diabetes globally is a significant driver for the DFU Treatment market. As the number of people living with diabetes continues to rise, so does the incidence of diabetic foot ulcers. For instance, according to the WHO’s factsheet for April 2023, the number of persons with diabetes increased from 108 million in 1980 to 422 million in 2014. Prevalence has increased faster in low- and middle-income nations than in high-income countries. Growing awareness about diabetes-related complications, including foot ulcers, has led to early detection and intervention. Increased education among patients and healthcare professionals helps prevent and manage diabetic foot ulcers effectively. Furthermore, integrating technology in healthcare, such as telemedicine and remote patient monitoring, facilitates more accessible and efficient management of diabetic foot ulcers. This can lead to better patient outcomes and increased adoption of treatment options.
However, advanced treatment modalities can be costly, including bioengineered skin substitutes, negative pressure wound therapy, and other innovative technologies. The high cost may limit accessibility for some patients and healthcare systems. Successful diabetic foot ulcer treatment often requires strict adherence to wound care regimens, offloading techniques, and lifestyle modifications. Challenges in patient compliance can hinder treatment efficacy. Additionally, limited access to specialized care, increasing antibiotic resistance, and coexisting comorbidities are some restraints impeding the overall market growth.
Diabetic Foot Ulcer Treatment Market Ecosystem
The global diabetic foot ulcer treatment market is analyzed from the following perspectives: Type, Application, End User, and Region.
Diabetic Foot Ulcer Treatment Market by Type
Based on the type, the global diabetic foot ulcer treatment market is segmented into ischemic, neuro-ischemic, and neuropathic ulcers.
Neuro-ischemic ulcers hold the largest revenue share in the segment owing to a high prevalence of neuro-ischemic ulcers, thus, growth in the treatments. Furthermore, this type of foot ulcer has considerable concern about infection and amputation and could lead to fatality. Neuro-ischemic ulcers are a specific type of diabetic foot ulcer characterized by a combination of neuropathy (nerve damage) and ischemia (reduced blood flow) in individuals with diabetes. These ulcers result from the synergistic effects of both conditions, making them particularly challenging to manage. Treatment strategies for neuro-ischemic ulcers in the diabetic foot ulcer market involve addressing the dual challenges of impaired sensation and compromised blood flow. The treatment of neuro-ischemic ulcers in the diabetic foot ulcer market emphasizes a comprehensive and individualized approach to address both vascular and neuropathic components. Early intervention, diligent wound care, and a collaborative healthcare team contribute to better outcomes for individuals with this challenging condition.
Diabetic Foot Ulcer Treatment Market by Treatment Type
Based on the treatment type, the global diabetic foot ulcer treatment market is segmented into active therapies, wound care dressings, therapy devices, and others.
The wound care dressings segment accounted for a significant market share in 2023, attributed to high R&D activities and the continuous launch of new and innovative dressing products. The diabetic foot ulcer treatment market continually evolves by introducing new technologies and materials to improve wound healing outcomes. Healthcare professionals consider factors such as the wound's characteristics, patient preferences, and cost-effectiveness when selecting appropriate dressings for diabetic foot ulcers.
Therapy devices are an emerging segment at a significant rate and are estimated to register a noticeable revenue growth during the forecast period. The therapy devices segment can be classified as negative pressure wound therapy, ultrasound therapy, etc. Negative pressure wound therapy has gained much popularity in society. Furthermore, therapy devices provide a better recovery rate at an economical cost that economically low people can easily afford. Additionally, technological advancement can provide optimal results, thereby encouraging the revenue growth of this segment in the global diabetic foot ulcer treatment market.
Diabetic Foot Ulcer Treatment Market by End User
Based on the end user, the global diabetic foot ulcer treatment market is segmented into hospitals, clinics, ambulatory surgical centers, and home care centers.
The hospital segment is a key player in the diabetic foot ulcer treatment market, with the largest revenue share in 2023 attributed to large patient footfall and the availability of enhanced technologies. Additionally, this segment has a high patient satisfaction rate. Also, it offers better reimbursement policies, thus encouraging the market's revenue growth. Meanwhile, homecare centers, clinics, and ambulatory centers are expected to depict continuous development during the forecast period. These overall factors contribute to the growth of the hospital segment.
Diabetic Foot Ulcer Treatment Market by Region
Geographically, the global diabetic foot ulcer treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the global diabetic foot ulcer treatment market with the largest revenue share in 2022, attributed to the growing diabetes cases, The rapid adoption of enhanced technologies, the availability of developed healthcare infrastructure with significant healthcare expenditure, and the large base of international market players contribute to the dominance of the diabetic foot ulcer treatment market in this region. For instance, according to the Centers for Disease Control and Prevention’s article of November 2023, in 2021, the United States had 38.4 million diabetics, accounting for around 11.6% of the total population. Additionally, growing cases of diabetic foot ulcers because of the increasing practice of a sedentary lifestyle, physical inactivity, and a high population base for obese people are fuelling the revenue growth of the market.
Asia Pacific is also considered the fastest revenue-generating region in this market. This growth can be attributed to the rapid adoption of the latest technologies, development in the healthcare infrastructure, improving medical tourism, and increasing the prevalence of diabetes mellitus.
Diabetic Foot Ulcer Treatment Market Competitive Landscape
The prominent players operating in the global diabetic foot ulcer treatment market are:
Diabetic Foot Ulcer Treatment Market Strategic Developments
Diabetic foot ulcer is a common complication associated with diabetes mellitus, particularly in individuals with poorly controlled blood sugar levels.
The global diabetic foot ulcer treatment market was valued at US$ 3.95 billion in 2023.
The estimated market size of the global diabetic foot ulcer treatment market in 2032 is US$ 6.16 billion.
The revenue CAGR of the diabetic foot ulcer treatment market during the forecast period will be 5.7% from 2024 to 2032.
Some key companies operating in the global diabetic foot ulcer treatment market are 3M Healthcare, Integra LifeSciences Corporation, B. Braun Melsungen AG, ConvaTec Group Plc., Cardinal Health Inc., and Smith & Nephew Plc.
*Insights on financial performance are subject to the availability of information in the public domain
List of Tables
List of Figures